Nitrogen-containing heteroaryl compounds and methods of use thereof
AssigneeFibroGen, Inc.
InventorsMichael P. Arend, Lee A. Flippin, Volkmar Guenzler-Pukall, Wen-Bin Ho, Eric D. Turtle, Xiaohui Du
Life of this patent
Estimating the term…
Abstract
The present invention relates to compounds suitable for use in mediating hypoxia inducible factor and for treating erythropoietin-associated conditions by increasing endogenous erythropoietin in vitro and in vivo.
Claims12
A method of treating anemia associated with chronic kidney disease in a patient undergoing dialysis, comprising administering to the patient a therapeutically effective amount of a compound of formula:
- or a pharmaceutically acceptable salt thereof.
A method of treating anemia associated with chronic kidney disease in a patient undergoing dialysis, comprising administering to the patient a therapeutically effective amount of a compound of formula:
A method of treating anemia associated with chronic kidney disease in a patient who is not undergoing dialysis, comprising administering to the patient a therapeutically effective amount of a compound of formula:
- or a pharmaceutically acceptable salt thereof.
A method of treating anemia associated with chronic kidney disease in a patient who is not undergoing dialysis, comprising administering to the patient a therapeutically effective amount of a compound of formula:
Dependencies are inferred from the claim text.